Pharma-Bio Serv (PBSV) News Today → Trump’s arrest is phase one (From Porter & Company) (Ad) Free PBSV Stock Alerts $0.53 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 13 at 4:42 AM | americanbankingnews.comPharma-Bio Serv (OTCMKTS:PBSV) Stock Price Crosses Below Two Hundred Day Moving Average of $0.87May 18, 2024 | wsj.comPharma-Bio Serv Inc.May 14, 2024 | msn.comKörber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive RankingMay 2, 2024 | markets.businessinsider.comBBIO Stock Earnings: BridgeBio Pharma Beats EPS, Beats Revenue for Q1 2024April 25, 2024 | markets.businessinsider.comDeep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)April 25, 2024 | markets.businessinsider.comEQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché LaboratóriosApril 23, 2024 | markets.businessinsider.comBiomarin Pharmaceutical earnings preview: what Wall Street is expectingApril 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market ExpectationsApril 9, 2024 | tmcnet.comSanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com's Supplier Pre-assessment ProgramApril 3, 2024 | benzinga.comLooking Into Biomarin Pharmaceutical's Recent Short InterestMarch 19, 2024 | finance.yahoo.comPBSV Releases Quarterly ResultsMarch 19, 2024 | seekingalpha.comPharma-Bio Serv reports Q1 resultsMarch 4, 2024 | markets.businessinsider.comBuy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial OutlookMarch 4, 2024 | markets.businessinsider.comMaintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market UncertaintiesFebruary 26, 2024 | marketwatch.comBioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- UpdateFebruary 23, 2024 | markets.businessinsider.comStrong Voxzogo Performance Underpins Buy Rating for BioMarin PharmaceuticalJanuary 30, 2024 | finance.yahoo.comPBSV Expands Margins and MarketsJanuary 28, 2024 | msn.comJubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger DealJanuary 9, 2024 | markets.businessinsider.comOptimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth DriversJanuary 8, 2024 | seekingalpha.comBridgeBio Pharma's Robust Pipeline Could Benefit From A PartnerJanuary 3, 2024 | finance.yahoo.comPBSV Reward Shareholders with High YieldDecember 21, 2023 | finanznachrichten.dePharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special DividendDecember 8, 2023 | msn.comAbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?November 28, 2023 | markets.businessinsider.comBioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In GermanyNovember 7, 2023 | markets.businessinsider.comPromising Future for BridgeBio Pharma: Lebovitz’s Buy Rating Backed by Potential Blockbusters and Pipeline AssetsNovember 6, 2023 | markets.businessinsider.comBridgeBio Pharma Receives Buy Rating Amid Promising Drug Pipeline Developments and Strong Financial PositionSeptember 15, 2023 | finance.yahoo.comPBSV Boosts Margins and Expands MarketsSeptember 14, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023August 31, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Phibro Animal Health (PAHC)July 28, 2023 | thestreet.comPharma-Bio Serv IncJuly 17, 2023 | msn.comBridgeBio Pharma: Positive ATTR-CM Treatment Data Leads To Other 2023 CatalystsJuly 15, 2023 | marketwatch.comBridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease StudyJuly 15, 2023 | marketwatch.comStocks to Watch: BridgeBio Pharma, Universal Security Instruments, BYND Cannasoft EnterprisesJune 20, 2023 | technews.tmcnet.comPearl Bio Secures Breakthrough IP for Multi-Functionalized BiologicsJune 15, 2023 | finance.yahoo.comPBSV: A Consistent Performer with Impressive DividendJune 14, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023June 13, 2023 | ca.finance.yahoo.comTBPMF - Tetra Bio-Pharma Inc.June 10, 2023 | finance.yahoo.comPBSV - Pharma-Bio Serv, Inc.May 20, 2023 | msn.comAvid Bioservices Bolsters Manufacturing Capabilities And Generates High-Demand ServicesMay 15, 2023 | tmcnet.comBridgeBio Pharma to Present Updated Data from itsMay 10, 2023 | marketwatch.comBio Pharma Buffer Market Research | 2023-2030May 9, 2023 | marketwatch.comGlobal "Bio Pharma Logistics Market" 2023 Research Report | Enhanced Growth Size, Estimates and Regional Outlook by 2030 | Research Reports WorldApril 25, 2023 | markets.businessinsider.comHere's what Wall Street expects from Biomarin Pharmaceutical's earningsApril 20, 2023 | benzinga.comPharma-Bio Serv Stock (OTC:PBSV), Quotes and News SummaryApril 8, 2023 | marketwatch.comBio Pharma Buffer Market 2023 Size and Forecast to 2031March 20, 2023 | finance.yahoo.comPBSV: A Steady Performer with Upside PotentialMarch 17, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023March 7, 2023 | markets.businessinsider.com4 Analysts Have This to Say About BridgeBio PharmaMarch 3, 2023 | markets.businessinsider.comSVB Securities Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)February 21, 2023 | marketwatch.comBio Pharma Buffer Market 2023: Emerging Trends and Best Practices in Futurism till 2028 Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump conviction scandal exposed (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. PBSV Media Mentions By Week PBSV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBSV News Sentiment▼-1.000.88▲Average Business Services News Sentiment PBSV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBSV Articles This Week▼40▲PBSV Articles Average Week Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TSSI News Today LICN News Today LTBR News Today ISDR News Today WHLM News Today AERT News Today GOPH News Today CISO News Today RVYL News Today CTM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PBSV) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredDouble-Threat Biotech Could Deliver Triple-Digit GainsMost investors haven't heard of this under-the-radar biotech... But it could emerge as one of the premier A...Behind the Markets | Sponsored